32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

Intelligentes Trio: Antikörper-Wirkstoff-Konjugate gegen Krebs ADCs sind einer der Innovationsmotoren in der Onkologie. Die Medikamente verändern das Leben von Menschen mit Krebs schon heute nachhaltig. Die Pipelines sind gut gefüllt.

#ADCs sind einer der Innovationsmotoren in der #Onkologie. Die #Medikamente verändern das Leben von Menschen mit #Krebs schon heute nachhaltig. Die #Pipelines sind gut gefüllt.

pharma-fakten.de/news/intelli...

Daiichi Sankyo gears up for five ADC launches in 2026

#DaiichiSankyo #ADCs #ADClaunches #Enhertu #Datroway #breastcancer #Oncology #antibodydrugconjugates #trastuzumabderuxtecan #datopotamabderuxtecan #pertuzumab #earlystagebreastcancer #triplenegativebreastcancer #Ifinatamabderuxtecan #IDXd #TROPIONBreast05study #ADCtechnology
zurl.co/TySHW

THE ULTIMATE GUIDE TO WINDOWS COERCION TECHNIQUES IN 2025 Windows authentication coercion is still a powerful AD primitive: it forces predictable auth flows and enables relay chains. Modern mitigations reduce easy abuse, but when combined with AD CS o

Original text by redteampt


Windows authentication coercion remains a strong AD attack primitive because it enables deterministic forced authentication instead of relying on chance. #ActiveDirectory #ADCS #attacks #exploitation #windows
core-jmp.org/?p=249

Recent advances in bispecific antibody-drug conjugates for breast cancer therapy Bispecific antibody–drug conjugates represent a promising strategy to overcome the limitations of conventional ADCs in breast cancer, such as tumor heterogeneity and inefficient internalization.

Bispecific antibody–drug conjugates represent a promising strategy to overcome the limitations of conventional #ADCs in #BreastCancer, such as tumor heterogeneity and inefficient internalization.

Full story 👉 buff.ly/gQFqeyF

#OncSky

Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment - Nature Reviews Cancer Antibody–drug conjugates are rapidly expanding both in the clinical treatment of cancer and in preclinical development. In this Review, Zippelius et al. highlight the molecular interactions and immune system effects of these sophisticated drugs that drive their efficacy and toxicity.

🥳And coming it at number 1🥁🥁🥁....
Our 1st most downloaded #REVIEW in 2025:

Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment

#ADCs #antibodydrugconjugates @NatResCancer
#NRCtop10of2025

Four years running now, still managing to keep my lab root CA alive! I think the VM has been moved 3 or 4 times at this point, but I still keep managing to publish a new CRL! #PKI #ADCS

Abi Siva: ADCs are Now Listed as a 1L Option in mTNBC - OncoDaily Abi Siva: ADCs are Now Listed as a 1L Option in mTNBC / Abi Siva, ADCs, Breast Cancer, cancer, Dato-DXd, mTNBC, NCCN, OncoDaily, Oncology, Paolo Tarantino

ADCs are Now Listed as a 1L Option in mTNBC - Abi Siva

@abisivamd.bsky.social @ptarantinomd.bsky.social

oncodaily.com/voices/abi-s...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADCs #mTNBC

MASCC Shares New Video on Managing Nausea and Vomiting in ADC Therapy - OncoDaily MASCC Shares New Video on Managing Nausea and Vomiting in ADC Therapy / cancer, Florian Scotte, Hope Rugo, Maryam Lustberg, MASCC, OncoDaily, Oncology

MASCC Shares New Video on Managing Nausea and Vomiting in ADC Therapy

@cancercaremascc.bsky.social

oncodaily.com/voices/mascc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #MASCC #ADCTherapy #ADCs #Nausea #Vomiting

Stephen V Liu: More on the Resistance to ADCs in the Journal of Thoracic Oncology - OncoDaily Stephen V Liu: More on the Resistance to ADCs in the Journal of Thoracic Oncology / Alissa Poteete, Ash A. Alizadeh, Ashwani Kumar, cancer, Caroline M.

More on the Resistance to ADCs in the Journal of Thoracic Oncology - Stephen V Liu

@stephenvliu.bsky.social

oncodaily.com/voices/steph...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADCs #ThoracicOncology #LungCancer #NSCLC

NEW WORKSHOP "Top-Down, Intact, and Native Mass Spectrometry in Biopharmaceutical Characterization" Feb.12, 2026. Speakers from #AstraZeneca, #Novartis, #Pfizer, #Genentech, #Sanofi, #JnJ, #Lilly and #NIBRT share stories and perspectives. > ctdp.org/biopharma-wo... #ADCs #mAbs #BsAbs #TsAbs #AAVs

Antengene Showcases Groundbreaking Advances at JPM Conference: What's Next for ADCs and TCEs? Antengene Corporation Limited presents significant clinical data and strategic directions for next-generation ADCs and TCEs at the JPM Healthcare Conference, highlighting their future potential.

Antengene Showcases Groundbreaking Advances at JPM Conference: What's Next for ADCs and TCEs? #USA #San_Francisco #Antengene #ADCs #TCEs

ADTrapper processes Windows AD auth logs with 54+ detection rules (brute force, password-spray, ADCS), accepts SharpHound collections, and offers force-directed graphs for relationship analysis. Containerized and anonymous uploads. #tool #ADTrapper #ADCS https://bit.ly/4jGMjUa

Unchained Labs Introduces Innovative ADC Characterization Tool for Researchers Unchained Labs enriches the research landscape with a new application that simplifies ADC characterization, enhancing the development process for researchers.

Unchained Labs Introduces Innovative ADC Characterization Tool for Researchers #USA #Pleasanton #ADCs #Unchained_Labs #Stunner

Closed & Collaborative H2 2025: Mergers, acquisitions, partnerships, collaborations, and strategic agreements The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.

#RNA #ADCs #earlyphaseclinicalservices #biosimilars #marketentry #platformlicensing #Radiopharmaceuticals #hospitalAI #CDxpartnerships #genomicsequencing #biomarkerdiscovery #Digitalhealth #biologics #specialtymedicines #precisionmedicine #MandA #licensingagreements
zurl.co/ch3Xg

Antibody–Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy
www.mdpi.com/2673-9992/40...

By Angel Justiz-Vaillant
From the 1st International Online Conference by Antibodies

#ADCs #AutoimmuneDiseases #TargetedTherapy #Immunotherapy

🙏 Merci à nos contributeurs

En 2025, Hugues Moccand, a contribué avec l’écriture d’un cours IT :

📘 Maîtrisez l’Autorité de certification avec AD CS sous Windows Server
www.it-connect.fr/cours/ad-cs-...

#Windows #Certification #ADCS #ITConnect #Contributeurs #Merci

🚨 New BioFlux Newsletter! Critical ADC safety hold on Daiichi Sankyo & Merck. Landmark approvals: Omeros' Yartemlea for TA-TMA & Edwards' SAPIEN M3 for mitral valve. Dive into biotech & health tech trends! Read now: #BioFlux #Biotech #HealthTech #ADCs #Nextechie

Allink Biotherapeutics Raises $47M to Propel Clinical Advancements and Innovative Drug Platforms Allink Biotherapeutics, Inc. has successfully completed $47 million extension rounds of Series A, accelerating its clinical development efforts for unique antibody-drug conjugates.

Allink Biotherapeutics Raises $47M to Propel Clinical Advancements and Innovative Drug Platforms #Shanghai #USA #oncology #Allink_Biotherapeutics #ADCs

Allink Biotherapeutics Secures $47 Million in Series A Funding to Propel Clinical Programs Forward Allink Biotherapeutics has successfully raised $47 million in additional Series A funding led by Legend Capital and Meituan Long-Z Investment, aiming to escalate their clinical programs.

Allink Biotherapeutics Secures $47 Million in Series A Funding to Propel Clinical Programs Forward #Shanghai #USA #oncology #Allink_Biotherapeutics #ADCs

What’s powering the next wave of life sciences investment in the UK and Nordics?

#lifesciences #biotech #healthtech #medtech #lifesciencesinvestment #UK #Nordics #LifeSciencesInvestmentTrends #medicaldevices #oncology #ADCs #preclinicaloncology #neurodegenerativeconditions #GLP1s #nextgenGLP1 #metabolicobesityspace #biopharma #AI #IPOpipeline #IPOmarket
zurl.co/LOrXD

ADC Cancer Treatment in China: Next-Gen Targeted Therapies | MedBridgeNZ Discover advanced ADC cancer treatment in China before global rollout. As your medical concierge, MedBridgeNZ connects you with top specialists for these next-gen therapies. Not a medical provider.

The future of oncology is shifting. The explosive rise of ADC cancer treatment in China—the "magic bullets" that Merck and AstraZeneca are spending billions to acquire.


Read more: zurl.co/N9JLR

#ADCs #CancerTreatment #China #MedicalConcierge #MedicalTourismChina

New episode! 🎧
Host @stephenvliu.bsky.social talks with Prof. Li Zhang and Dr. Elaine Shum about how ADCs are reshaping treatment for EGFR-mutant NSCLC, from new approvals to next-gen agents on the horizon.

Listen here: bit.ly/3XyFycL

#LungCancer #NSCLC #EGFR #ADCs #CancerResearch

🔎 Vous avez une autorité de certification sous AD CS et vous désirez délivrer un certificat pour un serveur Web Linux ?

Alors, suivez ce tutoriel pas à pas ! 😊

👉 A découvrir par ici : www.it-connect.fr/ad-cs-commen...

#ADCS #Web #Linux #sysadmin

BioDlink Unveils Major Advances in Biologics Development Between Europe and China BioDlink showcases its pivotal role in biopharmaceuticals at Biologics CDMO Europe 2025, marking a significant advancement in global collaboration.

BioDlink Unveils Major Advances in Biologics Development Between Europe and China #China #Suzhou #ADCs #Biologics #BioDlink

AD CS : comment renouveler les certificats d’une autorité racine et intermédiaire ?

👇 Le tuto
www.it-connect.fr/ad-cs-commen...

#ADCS #PKI #Adminsys #WindowsServer #Elearning

𝗥𝗲𝘁𝗿𝗼𝘂𝘃𝗲𝘇 𝗻𝗼𝘀 𝘁𝘂𝘁𝗼𝘀 𝗲𝘁 𝗰𝗼𝘂𝗿𝘀 𝗮̀ 𝗲𝘅𝗽𝗹𝗼𝗿𝗲𝗿 𝗰𝗲 𝗹𝗲 𝘄𝗲𝗲𝗸-𝗲𝗻𝗱 ! ⚡

Au programme sur IT-Connect et YouTube :
www.it-connect.fr/cours-tutori...

#Passbolt #Windows #Portainer #Traefik #CA #ADCS #ArxOneBackup #NSE #Nmap

📰 New & Featured | #Glycosylation site-specific ADCs (#gsADCs) harness the #Asn297 N-glycosylation site on the #IgG Fc for precise drug loading.
⚙️Workflow: glycosidase trim (e.g. endo S2) ➜ azide install via #GalT(#Y289L) ➜ cyclooctyne click → stable, uniform #ADCs.

📚MedChemExpress Digest | #DrugResistance in #TNBC
🎯#Chemotherapy resistance＆#immunotherapy resistance. Emerging Solutions: Combo immunotherapy, #vaccines, CAR-T/NK, #ADCs, targeted inhibitors, #ferroptosis, PDT, FMD & oncolytic viruses.
🔗https://ow.ly/PlC950XtTsB

Don’t miss Dr. Paolo Tarantino and experts discussing evolving ADC science at SABCS! Live + virtual on 12/11 at 7 PM CST.

Register: https://bit.ly/25ADCBreast-Sky
#BreastCancer #ADCs #SABCS